百股顺

中国人寿股票

Canaccord Genuity维持CRISPR Therapeutics评级为买入

   炒股配资 来源:TtMdJhSZN

同花顺(300033)美股讯 6月15日Canaccord Genuity维持CRISPR Therapeutics评级为买入,最新目标价为84.00美元。


https://www.illumina.com.cn/areas-of-interest/cancer/research/cancer-dna-sequencing/cancer-exome-seq.html